<html>
<head>PUBMED IDs for RGC32</head>
<body bgcolor='#C5F0F2'><h1>RGC32</h1><a href='https://pubmed.ncbi.nlm.nih.gov/15932515/'>Distinct gene expression patterns of peripheral blood cells in hyper-IgE syndrome.</a> June 4  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/17146433/'>RGC32, a novel p53-inducible gene, is located on centrosomes during mitosis and results in G2/M arrest.</a> December 6  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17935617/'>SOX9 transduction of a human chondrocytic cell line identifies novel genes regulated in primary human chondrocytes and in osteoarthritis.</a> October 16  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17935615/'>The histone deacetylase inhibitor belinostat (PXD101) suppresses bladder cancer cell growth in vitro and in vivo.</a> October 16  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17935613/'>DNA indels in coding regions reveal selective constraints on protein evolution in the human lineage.</a> October 16  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17935575/'>Okey Lecture 2006: identifying the neurobiological mechanisms of addictive behaviour.</a> October 16  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17935511/'>The homozygous deletion of the 3' enhancer of the SHOX gene causes Langer mesomelic dysplasia.</a> October 16  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17935510/'>Parkin polymorphisms: risk for Parkinson's disease in Indian population.</a> October 16  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/19478469/'>Molecular characterization of a new ovarian cancer cell line, YDOV-151, established from mucinous cystadenocarcinoma.</a> August 14  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20635389/'>Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer.</a> May 13  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20862745/'>Promoter methylation of the RGC32 gene in nonsmall cell lung cancer.</a> March 30  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/23715780/'>Overexpression of response gene to complement 32 (RGC32) promotes cell invasion and induces epithelial-mesenchymal transition in lung cancer cells via the NF-ÎºB signaling pathway.</a> December 16  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24833469/'>Knockdown of response gene to complement 32 (RGC32) induces apoptosis and inhibits cell growth, migration, and invasion in human lung cancer cells.</a> October 27  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25655049/'>Expression of RGC32 in human normal and preeclamptic placentas and its role in trophoblast cell invasion and migration.</a> December 15  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/28470188/'>RGC32 induces epithelial-mesenchymal transition by activating the Smad/Sip1 signaling pathway in CRC.</a> May 5  2017<br></body></html>
